Picture of Fulgent Genetics logo

FLGT — Fulgent Genetics News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousMid CapSuper Stock

Brief: Fulgent Reports Fourth Quarter And Full Year 2022 Financial Results

Feb 28 (Reuters) - Fulgent Genetics Inc  FLGT.O :
    * FULGENT REPORTS FOURTH QUARTER AND FULL YEAR 2022
FINANCIAL
RESULTS
    * FULGENT GENETICS INC - QTRLY GAAP LOSS OF $23.8 MILLION,
OR
$0.80 PER SHARE
    * FULGENT GENETICS INC - QTRLY NON-GAAP LOSS OF $14.2
MILLION, OR
$0.48 PER SHARE
    * FULGENT GENETICS INC - FOR Q1 OF 2023, FULGENT EXPECTS
TOTAL
REVENUE OF APPROXIMATELY $56.0 MILLION
    * FULGENT GENETICS INC - FOR FULL YEAR 2023, FULGENT EXPECTS
TOTAL
REVENUE OF APPROXIMATELY $240.0 MILLION
    * FULGENT GENETICS INC SEES 2023 GAAP LOSS OF APPROXIMATELY
$2.50
PER SHARE
    * FULGENT GENETICS INC SEES 2023 NON-GAAP LOSS OF
APPROXIMATELY
$1.25 PER SHARE

Source text for Eikon:  ID:nBw2xPdJGa 
Further company coverage:  FLGT.O 

 ((Reuters.Briefs@thomsonreuters.com;;))

Recent news on Fulgent Genetics

See all news